NOVARTIS AG BASEL AKT (NVSEF) Revenue by Year
NOVARTIS AG BASEL AKT generated $56.7B in revenue in fiscal year 2025. This represents an increase of 9.6% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters NOVARTIS AG BASEL AKT has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NVSEF Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
NVSEF Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More NOVARTIS AG BASEL AKT financials
Frequently Asked Questions
What was NOVARTIS AG BASEL AKT's revenue in fiscal year 2025?
NOVARTIS AG BASEL AKT generated $56.7B in revenue in fiscal year 2025.
How fast is NOVARTIS AG BASEL AKT's revenue growing?
NOVARTIS AG BASEL AKT (NVSEF) revenue rose by 9.6% year over year, from $51.7B to $56.7B in fiscal year 2025.
How has NOVARTIS AG BASEL AKT's revenue changed over the years?
Across the 11 fiscal years this page covers, NOVARTIS AG BASEL AKT (NVSEF) revenue went from $50.4B in fiscal year 2015 to $56.7B in fiscal year 2025.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what NOVARTIS AG BASEL AKT (NVSEF) reported on that line in every period on record.